Peptide Therapy

Peptide therapy uses short chains of amino acids (peptides) that signal specific cellular processes in the body. The most common protocols at AVAANDI MedSpa fall into two families: growth-hormone secretagogues (sermorelin, ipamorelin, CJC-1295) that prompt your own pituitary to release growth hormone in natural pulses, and tissue-repair peptides (BPC-157, TB-500) that support soft-tissue healing. All peptides are physician-prescribed, lab-guided, and dose-titrated to each patient.

AVAANDI MedSpa offers sermorelin, ipamorelin + CJC-1295 (combination), and tesamorelin for growth-hormone axis support; BPC-157 and TB-500 for soft-tissue repair and recovery; and selective peptides for sleep, cognition, and lean-mass preservation. Specific availability and protocol selection are determined at consultation based on labs, symptoms, and goals. We are transparent that BPC-157 and TB-500 are research peptides without FDA approval for human use — that conversation happens upfront at consult.

TRT and BHRT directly replace a hormone the body is no longer producing in sufficient quantity. Peptide therapy, by contrast, signals the body's own glands to produce more of its hormones (or supports cellular repair pathways). For growth-hormone axis support specifically, peptides like sermorelin work with the body's natural circadian pulse rather than overriding it. Many AVAANDI patients combine peptides with TRT or BHRT for compounding benefit.

Sleep improvements are often noticed within the first 1–2 weeks of growth-hormone peptide therapy. Recovery and energy benefits typically emerge by 4–8 weeks. Body-composition and lean-mass changes are usually visible by 12–16 weeks of consistent dosing combined with resistance training and adequate protein intake. BPC-157 protocols for soft-tissue healing often show benefit within 2–6 weeks depending on injury severity.

Growth-hormone secretagogue peptides like sermorelin have a well-established safety profile when prescribed and monitored by a clinician. Common, usually mild, side effects include injection-site reactions, water retention, and occasional headache. Because peptides like BPC-157 and TB-500 are research compounds without full FDA approval, AVAANDI MedSpa reviews the current evidence, source quality, and individualized risk profile with every patient before prescribing. Lab monitoring (IGF-1, glucose, metabolic panel) is part of every protocol.